Filing Details

Accession Number:
0001193805-25-000646
Form Type:
13G Filing
Publication Date:
2025-05-12 20:00:00
Filed By:
Deerfield Mgmt, L.P.
Company:
Mallinckrodt Plc (NYSE:NONE)
Filing Date:
2025-05-13
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Deerfield Mgmt, L.P. 0 804,258 4.07%
Deerfield Mgmt IV, L.P. 0 1 0%
Deerfield Partners, L.P. 0 804,258 4.07%
Deerfield Private Design Fund IV, L.P. 0 1 0%
Deerfield Management Company, L.P. 0 804,259 4.07%
James E. Flynn 0 804,259 4.07%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Comprised of ordinary shares, par value $0.01 per share ("Ordinary Shares") held by Deerfield Partners, L.P., of which Deerfield Mgmt, L.P. is the general partner.


SCHEDULE 13G



Comment for Type of Reporting Person:  Comprised of 1 Ordinary Share held by Deerfield Private Design Fund IV, L.P., of which Deerfield Mgmt IV, L.P. is the general partner.


SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G



Comment for Type of Reporting Person:  Comprised of 804,258 Ordinary Shares held by Deerfield Partners, L.P. and 1 Ordinary Share held by Deerfield Private Design Fund IV, L.P., of which Deerfield Management Company, L.P. is the investment advisor.


SCHEDULE 13G



Comment for Type of Reporting Person:  Comprised of 804,258 Ordinary Shares held by Deerfield Partners, L.P. and 1 Ordinary Share held by Deerfield Private Design Fund IV, L.P.


SCHEDULE 13G


 
Deerfield Mgmt, L.P.
 
Signature:/s/ Jonathan Isler
Name/Title:Jonathan Isler, Attorney-In-Fact
Date:05/13/2025
 
Deerfield Mgmt IV, L.P.
 
Signature:/s/ Jonathan Isler
Name/Title:Jonathan Isler, Attorney-In-Fact
Date:05/13/2025
 
Deerfield Partners, L.P.
 
Signature:/s/ Jonathan Isler
Name/Title:Jonathan Isler, Attorney-In-Fact
Date:05/13/2025
 
Deerfield Private Design Fund IV, L.P.
 
Signature:/s/ Jonathan Isler
Name/Title:Jonathan Isler, Attorney-In-Fact
Date:05/13/2025
 
Deerfield Management Company, L.P.
 
Signature:/s/ Jonathan Isler
Name/Title:Jonathan Isler, Attorney-In-Fact
Date:05/13/2025
 
James E. Flynn
 
Signature:/s/ Jonathan Isler
Name/Title:Jonathan Isler, Attorney-In-Fact
Date:05/13/2025
Exhibit Information

Exhibit A. Joint Filing Agreement. Exhibit B. Item 8 Statement. Exhibit C. Power of Attorney (1). (1) Power of Attorney previously filed as Exhibit 24 to a Form 3 with regard to BiomX Inc. filed with the Securities and Exchange Commission on March 19, 2024 by Deerfield Private Design Fund V, L.P., Deerfield Healthcare Innovations Fund II, L.P., Deerfield Mgmt V, L.P., Deerfield Mgmt HIF II, L.P., Deerfield Management Company, L.P. and James E. Flynn.